Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 14/20 | 0.60 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.53 |
| ▸ | CALM1 | P0DP23 | 1/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.51 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.51 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.51 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.51 |
| ▸ | HTT | P42858 | 1/20 | 0.51 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | CASP3 | P42574 | 1/20 | 0.46 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.46 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6468896 | 0.83 | LTA4H (0.67) | LTA4HL3MBTL1CYP1A2CYP2D6CYP2C9 | |
| SCHEMBL2093453 | 0.83 | LMNA (0.67) | LTA4HL3MBTL1CYP1A2CYP2C19LMNA | |
| SCHEMBL933 | 0.81 | — | — | |
| SCHEMBL11856925 | 0.80 | LMNA (0.69) | LTA4HL3MBTL1CYP1A2CYP2C19LMNA | |
| SCHEMBL10599543 | 0.80 | LMNA (0.69) | LTA4HL3MBTL1CYP1A2CYP2C19LMNA | |
| SCHEMBL8672820 | 0.80 | LTA4H (0.74) | LTA4HL3MBTL1CALM1CYP1A2CYP2D6 | |
| Hydrochloric Acid SCHEMBL27692384 | 0.79 | KCNA3 (0.55) | LTA4HCYP2C9CYP2C19LMNA | |
| SCHEMBL1912758 | 0.78 | LTA4H (0.71) | LTA4HL3MBTL1CALM1CYP1A2CYP2D6 | |
| SCHEMBL10062561 | 0.78 | LTA4H (0.63) | LTA4HL3MBTL1CALM1CYP1A2CYP2D6 | |
| SCHEMBL29127296 | 0.78 | LTA4H (0.60) | LTA4HL3MBTL1CALM1CYP1A2CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4252716-A | BLUE SHADES | BAYER AKTIENGESELLSCHAFT (DE) | 1981-02-24 | — | — | US | claimed |
| US-3991042-A | Basic azo dyestuffs containing a benzthiazole and a tetrahydroquinoline nucleus | BAYER AKTIENGESELLSCHAFT (DT) | 1976-11-09 | — | — | US | claimed |
| CN-112204073-B | Polymeric material and intraocular lens | 上海富吉医疗器械有限公司 | 2023-05-09 | — | — | CN | disclosed |
| CN-115073661-A | Resin composition and display device using same | 三星显示有限公司 | 2022-09-20 | — | — | CN | disclosed |
| US-20210292447-A1 | POLYMER MATERIAL AND INTRAOCULAR LENS | SHANGHAI FULO MEDICAL INSTRUMENT CO., LTD. (CN) | 2021-09-23 | — | — | US | disclosed |
| EP-3805290-A1 | POLYMER MATERIAL AND INTRAOCULAR LENS | Shanghai Chartwell Medical Instrument Co., Ltd (CN) | 2021-04-14 | — | — | EP | disclosed |
| CN-112204073-A | Polymer material and intraocular lens | 上海富吉医疗器械有限公司 | 2021-01-08 | — | — | CN | disclosed |
| WO-2019228224-A1 | POLYMER MATERIAL AND INTRAOCULAR LENS | 上海富吉医疗器械有限公司 (CN) | 2019-12-05 | — | — | WO | disclosed |
| US-8163753-B2 | 2-(4-(4-(4-chlorophenyl)oxazol-2-yl)phenoxymethyl)-2-methyl-6-nitro-2,3-dihydroimidazo[2,1-b]oxazole; bactericide; excellent bactericidal action against Mycobacterium tuberculosis, multi-drug-resistant Mycobacterium tuberculosis, and atypical acid-fast bacteria | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2012-04-24 | — | — | US | disclosed |
| EP-1678185-B1 | 2,3-DIHYDRO-6-NITROIMIDAZO [2,1-B] OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS | OTSUKA PHARMA CO LTD (JP) | 2008-10-08 | — | — | EP | disclosed |
| US-20080119478-A1 | 2,3-Dihydro-6-Nitroimidazo (2,1-b) Oxazole Compounds for the Treatment of Tuberculosis | OTSUKA PHAMACEUTICAL CO., LTD. (JP) | 2008-05-22 | — | — | US | disclosed |
| US-5719306-A | ANTIINFLAMMATORY AGENTS | G.D. SEARLE & CO. (US) | 1998-02-17 | — | — | US | disclosed |
| US-5717004-A | COMPRISES ATLEAST TWO ACRYLOYL GROUP CONTAINING COMPOUNDS WHEREIN THE ACRYLOYL GROUP IS FLUOROACRYLOYL, METHACRYLOYL OR ACRYLOYL; HIGH MECHANICAL STRENGTH | DAINIPPON INK & CHEMICALS, INC. (JP) | 1998-02-10 | — | — | US | disclosed |
| EP-0435354-B1 | Active energy ray-curable composition and applicable method | DAINIPPON INK & CHEMICALS (JP) | 1995-09-06 | — | — | EP | disclosed |
| EP-0289325-B1 | METHOD OF INCREASING THE DYNAMICAL STRENGTH OF GLASS CONTAINER | DAINIPPON INK AND CHEMICALS, INC. (JP) | 1993-06-16 | — | — | EP | disclosed |
| EP-0435354-A2 | Active energy ray-curable composition and applicable method | DAINIPPON INK AND CHEMICALS, INC. (JP) | 1991-07-03 | — | — | EP | disclosed |
| US-4961976-A | COATING WITH SILANE COUPLING AGENT AND ACRYLATED RESIN | DAINIPPON INK & CHEMICALS, INC. (JP) | 1990-10-09 | — | — | US | disclosed |
| US-4891241-A | COUPLING AGENT, PHOTOPOLYMERIZABLE MONOMER | DAINIPPON INK & CHEMICALS, INC. (JP) | 1990-01-02 | — | — | US | disclosed |
| EP-0289325-A1 | Method of increasing the dynamical strength of glass container | DAINIPPON INK AND CHEMICALS, INC. (JP) | 1988-11-02 | — | — | EP | disclosed |
| EP-0004334-B1 | CARBAMATES AND THEIR PESTICIDAL COMPOSITIONS, PREPARATIONS THEREOF AND USE THEREOF AS PESTICIDES | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) | 1981-10-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080119478-A1 | 2,3-Dihydro-6-Nitroimidazo (2,1-b) Oxazole Compounds for the Treatment of Tuberculosis | NR2C2, NR0B2, NR4A2 | LTA4H 3093/4885L3MBTL1 2575/4885CALM1 3356/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.